Dr. Kamal Khanna is one of the recipients of UConn Health’s 2016 SPARK Grant Competition. These awards aim to help investigators move ideas into the earliest stages of commercialization and development. Dr. Khanna’s project is focused on determining the efficacy of novel vaccine technology developed by Carogen Corporation in preventing and treating Clostridium Difficile infections, which are the most commonly acquired infections in hospitals.
